Cytokine-Regulated GADD45G Induces Differentiation and Lineage Selection in Hematopoietic Stem Cells  by Thalheimer, Frederic B. et al.
Stem Cell Reports
ReportCytokine-Regulated GADD45G Induces Differentiation and Lineage
Selection in Hematopoietic Stem Cells
Frederic B. Thalheimer,1,2 Susanne Wingert,1,2 Pangrazio De Giacomo,2 Nadine Haetscher,1,2
Maike Rehage,1,2 Boris Brill,2 Fabian J. Theis,3,4 Lothar Hennighausen,5 Timm Schroeder,6
and Michael A. Rieger1,2,7,8,*
1LOEWE Center for Cell and Gene Therapy and Department for Hematology/Oncology, Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt amMain,
Germany
2Georg-Speyer-Haus, Paul-Ehrlich-Strasse 42-44, 60596 Frankfurt am Main, Germany
3Institute of Computational Biology, Helmholtz Zentrum Munich, Ingolstaedter Landstrasse 1, 85764 Neuherberg, Germany
4Department of Mathematics, TU Munich, Boltzmannstrasse 3, 85747 Garching, Germany
5Laboratory of Genetics and Physiology, NIDDK, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA
6Department of Biosystems Science and Engineering (D-BSSE), ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland
7German Cancer Consortium (DKTK), Heidelberg, Germany
8German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
*Correspondence: m.rieger@em.uni-frankfurt.de
http://dx.doi.org/10.1016/j.stemcr.2014.05.010
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYThe balance of self-renewal and differentiation in long-term repopulating hematopoietic stem cells (LT-HSC) must be strictly controlled
to maintain blood homeostasis and to prevent leukemogenesis. Hematopoietic cytokines can induce differentiation in LT-HSCs; how-
ever, the molecular mechanism orchestrating this delicate balance requires further elucidation. We identified the tumor suppressor
GADD45G as an instructor of LT-HSC differentiation under the control of differentiation-promoting cytokine receptor signaling.
GADD45G immediately induces and accelerates differentiation in LT-HSCs and overrides the self-renewal program by specifically
activating MAP3K4-mediated MAPK p38. Conversely, the absence of GADD45G enhances the self-renewal potential of LT-HSCs.
Videomicroscopy-based tracking of single LT-HSCs revealed that, once GADD45G is expressed, the development of LT-HSCs into
lineage-committed progeny occurred within 36 hr and uncovered a selective lineage choice with a severe reduction in megakaryo-
cytic-erythroid cells. Here, we report an unrecognized role of GADD45G as a central molecular linker of extrinsic cytokine differentiation
and lineage choice control in hematopoiesis.INTRODUCTION
For an adequate quantitative production of each blood cell
lineage in homeostasis and in stress conditions, the fate of
hematopoietic stem cells (HSCs) to either differentiate or
to self-renew must be strictly controlled (Orkin and Zon,
2008). In recent years, increasing knowledge of the many
factors that contribute to the long-term maintenance of
HSCs in the bone marrow (BM) niche was gained (Trumpp
et al., 2010). Coordinated blood regeneration also needs
HSCs to leave their quiescent state and differentiate into
functional progeny, but little is known about molecules
that control the initial differentiation step. Extrinsic stim-
uli such as cytokines have been implicated in this process
(Metcalf, 2008). Cytokines are essential for blood cell
generation by controlling proliferation, survival, differenti-
ation, maturation, and function in a stage- and cell-type-
specific manner (Metcalf, 2008; Rieger and Schroeder,
2009). Only in recent years it could be proved that cyto-
kines also have instructive lineage choice capacity (Rieger
et al., 2009; Sarrazin et al., 2009). Cell intrinsic factors,
like transcription factors, can instruct the differentiation
of distinct lineages, even across normal lineage boarders34 Stem Cell Reports j Vol. 3 j 34–43 j July 8, 2014 j ª2014 The Authors(Xie et al., 2004). However, their ability ofmaking decisions
rather than only executing them is controversial (Graf
and Enver, 2009). So far, there have been rare examples
that linked extrinsic stimuli with intrinsic differentiation
and lineage choice mechanisms in hematopoiesis (Mossa-
degh-Keller et al., 2013; Sarrazin et al., 2009).
The expression of growth arrest and DNA-damage-
induced 45 gamma (Gadd45g), a member of the Gadd45
family consisting of Gadd45a, b, and g, is induced by cyto-
kines in myelomonocytic cells (Zhang et al., 1999) and
dependent on signal transducer and activator of transcrip-
tion (STAT) 5 (Hoffmeyer et al., 2001). GADD45G caught
our interest because of its role as DNA-damage response
and tumor suppressor gene that is epigenetically silenced
inmanymalignancies (Liebermann et al., 2011).Moreover,
GADD45G is upregulated in LT-HSCs of aged mice with
reduced reconstitution ability (Rossi et al., 2005), and small
hairpin RNA (shRNA)-mediated knockdown of GADD45G
selected for aged HSCs with higher self-renewal potential
(Wang et al., 2012). The Gadd45 family genes are known
responders to environmental stressors such as radiation
or chemicals and have been implicated in cell-cycle arrest,
senescence, apoptosis, DNA repair and demethylation, as
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including the hematopoietic system (Chen et al., 2014;
Moskalev et al., 2012). However, the function ofGADD45G
in LT-HSCs has not been investigated yet.
Therefore, we decided to assess the function of
GADD45G in the early HSC fate decision between self-
renewal and differentiation and identified GADD45G as a
rapid inducer and accelerator of HSC differentiation with
selective lineage choice ability under the control of differ-
entiation-promoting cytokines.RESULTS
GADD45G Is Activated by Cytokines and Immediately
Induces the Differentiation in LT-HSCs
Because the expression of Gadd45 genes can be activated
by various hematopoietic cytokines, we tested their ability
to induce Gadd45 expression also in LT-HSCs. Stimulation
of purified murine LT-HSCs (CD150+ CD48 CD34lo
CD117+ Sca1+ lineage) with the cytokine thrombopoietin
(TPO) substantially increased the expression of Gadd45g,
but did not change Gadd45a and Gadd45b expression
(Figure 1A and Figure S1A available online). Next, we inves-
tigated if the Gadd45 genes are induced also by other
cytokines in multipotent progenitors (MPPs). Whereas
Gadd45a is not regulated by interleukin (IL) -3, IL-6, and
TPO, Gadd45b is upregulated only upon IL-6 stimulation
and Gadd45g is strongly induced by all tested cytokines
(Figure 1B). Because mainly the expression of Gadd45g
was regulated in immature hematopoietic stem and pro-
genitors (HSPCs) by various cytokines, we focused on the
role of Gadd45g in early hematopoietic cell-fate decisions.
In order to simulate the consequences of cytokine-
induced GADD45G expression in LT-HSCs, we ectopically
expressed GADD45G in LT-HSCs by lentiviral transduction
(Figure S1B) and determined the status of differentiation
after 5, 8, and 10 days in culture by fluorescence-activated
cell sorting (FACS) (Figure 1C). The transduced cells were
distinguished by coexpression of a fluorescent protein.
The differentiation processwas initiated and strongly accel-
erated in LT-HSCs once GADD45G was expressed (Figures
1D and 1E). The percentage of immature HSPCs decreased
rapidly after induction of GADD45G expression (Figure 1E,
left). Although only 5% of the control-transduced LT-HSCs
expressed markers for granulocyte-macrophage (GM) pro-
genitors (GMPs) at day 5, already 45%of theGADD45G-ex-
pressing LT-HSCs reached the GMP stage of differentiation
(Figure 1E, middle), and the majority of cells have differen-
tiated into mature GM cells (CD11b+/CD16/32+) already at
day8 (Figure 1E, right). DimerizationofGADD45G is neces-
sary formanyof its functions, andpointmutations either at
amino acid position 79 (T79E) or 80 (L80E) of GADD45Ginhibit dimerization (Schrag et al., 2008). Both mutants
lost their ability to induce differentiation in LT-HSCs (Fig-
ure 1F), and we included L80E as additional negative
control in our assays. Next, we confirmed our findings at
the clonal functional level by colony formation assays.
Although the potential of LT-HSCs to form colonies was
unchanged by GADD45G, their ability to form secondary
colonies after replating was severely decreased, indicating
thatGADD45Gaccelerates their differentiation (Figure 1G).
To assess the differentiation kinetics of LT-HSCs into GMPs
induced by GADD45G at the single-cell level, we continu-
ously observed individual LT-HSCs and their progeny
by time-lapse microscopy and cell tracking, a technology
that records individual cell behavior in ontogeny pedigrees
(Kimura et al., 2009; Rieger et al., 2009). LT-HSCswere trans-
duced with lentiviruses coding for GADD45G or a control
and were immediately administered to time-lapse micro-
scopy (Figure 1H). GADD45G expression did not alter the
cell-cycle time in LT-HSCs or their progeny in subsequent
generations (Figure 1I). We measured the time interval
between the onset of transgene expression (determined
by nuclear membrane tdTOMATO) and expression of
surface CD16/32 indicating the GMP-like stage of develop-
ment.On average, LT-HSCs differentiated in only 36hr into
committed cells of the GMP stage when GADD45G was
expressed, whereas control-transduced LT-HSCs required
more than 84 hr (Figure 1J).
Based on these findings, we concluded that GADD45G
is a rapid inducer of LT-HSC differentiation. Next we ad-
dressed the question whether GADD45G can also over-
come an enhanced self-renewal program in LT-HSCs. We
cotransduced LT-HSCs with lentiviral vectors coding for
GADD45G (VENUS+) and NUP98-HoxA10 homeodomain
(referred as NA10, TOMATO+), a potent inducer of self-
renewal divisions (Ohta et al., 2007). When both programs
were expressed at the single-cell level, initially the differen-
tiation was prolonged, but, after 14 days, all cells finally
were differentiated, whereas 39% of single NA10-express-
ing cells remained immature (Figures 1K and S1C).
GADD45G Switches HSCs from Their Self-Renewal
Program into Differentiation In Vivo
GADD45G rapidly initiates the differentiation program
in LT-HSCs in vitro, but it was unclear whether LT-HSCs
maintain their self-renewal program under optimal in vivo
conditions. Hence, we competitively transplanted LT-
HSCs either expressing GADD45G or control (VENUS+) in
lethally irradiated recipients and determined the reconsti-
tution of T, B, andmyeloid cells by FACS (Figure 2A). Donor
LT-HSCs of both groups successfully homed and engrafted
into the BM, as almost equal numbers of mature blood cells
were generated 14 days after transplantation (Figure 2B).
However, although in the control group the bloodStem Cell Reports j Vol. 3 j 34–43 j July 8, 2014 j ª2014 The Authors 35
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Figure 1. Cytokine-Stimulated GADD45G Expression Induces and Accelerates Differentiation in LT-HSCs
(A and B) Quantitative RT-PCR of Gadd45 genes in LT-HSCs (A) and MPPs (B) stimulated with cytokines. n = 3 experiments. Relative
expression normalized to B2m.
(C–F) (C) Experimental scheme of (D)–(F). (D) Representative FACS blots of cultured LT-HSCs, gated for GADD45G and control-transduced
cells (VENUS+).
(E and F) Quantification of FACS results after 5, 8, and 10 days of culture. Transduced cells (VENUS+) were gated for immature HSPCs,
GMP-like cells and mature GM cells. n = 3 experiments.
(G) Colony formation assay of 200 LT-HSCs transduced with GADD45G and control and replating of 2,000 cells after 10 days. n = 3
experiments.
(H) Experimental scheme of (I) and (J).
(legend continued on next page)
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Figure 2. GADD45G Controls Self-
Renewal and Differentiation of LT-HSCs
In Vivo
(A) Experimental scheme of (B). BMMNCs,
bone marrow mononuclear cells.
(B) Transduced multilineage donor cell
reconstitution (VENUS+) was determined by
FACS in peripheral blood (PB) and in bone
marrow (BM) of primary (1) and secondary
(2) recipients (six and eight mice per
condition for 1 and 2 transplantation,
respectively). Initial transduction effi-
ciency in LT-HSCs was 45.4% (GADD45G)
and 52.1% (control).
(C) Experimental scheme of (D).
(D) LT-HSCs from adult Gadd45g/ and +/+
littermates were transplanted into lethally
irradiated recipients (five and 10–11 mice
per genotype for 1 and 2 transplantation,
respectively), and multilineage donor cell
reconstitution was measured by FACS in PB
and in BM of 1 and 2 recipients.
Data are represented as mean ± SEM. *p <
0.05, **p < 0.01. See also Figure S2.
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Hematopoietic Differentiation Induction by GADD45Greconstitution increased over time, GADD45G-expressing
cells were almost undetectable in the peripheral blood
(PB) already 4 weeks after transplantation, and no long-
term reconstitution was measured in PB or in BM (Fig-
ure 2B). In secondary transplantations, where the long-
term self-renewal ability of LT-HSCs is further challenged,
no GADD45G-positive cells engrafted, indicating a lack of
remaining LT-HSCs in the primary recipients (Figure 2B).
To examine the influences of GADD45G expression on
cell cycle or viability in vivo, we transplanted GADD45G-
expressing HSPCs, and determined both cell fates after 7
and 14 days in BM (Figure S2A). No changes in the rate of(I) Generation times of transduced LT-HSCs (generation 1) and their
(J) Interval of transgene expression (TOMATO+) and onset of CD16/3
eight pedigrees (control).
(K) Differentiation kinetics of double-transduced LT-HSCs (NA10, NUP
by FACS. n = 3 experiments.
Data are represented as mean ± SD. *p < 0.05, **p < 0.01. ns, not siproliferating (bromodeoxyuridine [BrdU]+) or viable cells
were seen in GADD45G-expressing cells (Figures S2B and
S2C). These data clearly show that GADD45G induces dif-
ferentiation at the expense of LT-HSC maintenance and
self-renewal also in vivo. GADD45G is neither inhibiting
cell proliferation nor survival and allows the generation
of mature progeny.
We then hypothesized that the absence of GADD45G
may lead to an enhanced self-renewal and a delayed differ-
entiation in LT-HSCs. Gadd45g has been germline deleted
in a mouse model (Lu et al., 2001), with no major conse-
quences for steady-state hematopoiesis (Figures S2D–S2F).progeny (TOMATO+) in subsequent generations.
2 expression (GMP-like stage). Data extracted from 29 (G45G) and
98-HOXA10 homeodomain and GADD45G) gated on immature HSPCs
gnificant. See also Figure S1.
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Figure 3. GADD45G Is Not Compatible
with Megakaryocyte-Erythroid Differen-
tiation and Thereby Selects for Lympho-
myeloid Lineages
(A) TdTOMATO+ megakaryocytes after a
7 day culture of 100 LT-HSCs. Transduction
efficiency was equal for both conditions.
n = 3 experiments.
(B) Colony formation assay of 200 LT-HSCs
transduced with GADD45G or control
under permissive cytokine conditions. n = 3
experiments.
(C) Experimental scheme of (D).
(D) Transplantation of transduced LSKs
in lethally irradiated recipients (four
mice per condition) and BM FACS after
11 days. Transduction efficiency was 59%
(GADD45G) and 72% (control).
(E) Example pedigrees illustrating the
filiation of continuously tracked LT-HSCs (at
the apex, generation 1) and all their prog-
eny in subsequent generations.
(F) Percentage of pedigrees with megakar-
yocyte development.
(G) Percentage of cell-death events in
each generation, before cells have differ-
entiated into GMP-like cells (CD16/32+).
Analyzed cell numbers are indicated.
(H and I) Colony formation assay of 400
MEPs or 200 GMPs transduced with
GADD45G or control. n = 3 experiments.
Data are represented as mean ± SD. *p <
0.05, **p < 0.01. See also Movie S1. See also
Figure S3.
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from Gadd45g/ and Gadd45g+/+ littermates and trans-
planted them competitively in lethally irradiated recipients
(Figure 2C). Although LT-HSCs from both groups equally
well reconstituted primary recipients, the Gadd45g/ BM
cells from primary recipients were superior in repopulating
secondary recipients (Figures 2D, S2G, and S2H). There-
fore, the absence of GADD45G increases the stemness of
LT-HSCs, most likely due to increased self-renewal.
GADD45G Selects for Lymphoid andMyelomonocytic
Differentiation at the Expense of
Megakaryocytic-Erythroid Lineage Fate
Megakaryocytes arise after several days culturing LT-HSCs,
but they were almost absent, when LT-HSCs were trans-
duced with GADD45G (Figure 3A). Next, we determined38 Stem Cell Reports j Vol. 3 j 34–43 j July 8, 2014 j ª2014 The Authorsthe megakaryocytic-erythroid (ME) potential in a colony
formation assay with LT-HSCs expressing GADD45G
in permissive cytokine conditions. Although 36% of col-
onies contained megakaryocytes and/or erythroid cells
from control or L80E-transduced LT-HSCs, we only scored
6.2% ± 2.5% of colonies with ME potential when
GADD45Gwas expressed (Figure 3B). Further, we addressed
whether LT-HSCs expressing GADD45G were able to
develop into ME progenitors (MEP) in vivo. We trans-
planted LSK (lineage CD117+ Sca1+) cells transduced
with GADD45G or control in lethally irradiated recipients
and determined the differentiation into committed pro-
genitors in the BM after 11 days (Figure 3C). Although we
did not detect a difference in the LSK or GMP compart-
ment, MEPs expressing GADD45G were absent, demon-
strating a lineage bias (Figure 3D). GADD45G might
Stem Cell Reports
Hematopoietic Differentiation Induction by GADD45Ginstruct a program of lymphoid and GM lineage choice in
multipotent cells. Alternatively, ME committed cells are
unable to mature when GADD45G is expressed, which
will lead to a selective elimination of these lineages. To
discriminate both scenarios, we analyzed the development
of LT-HSCs into GMPs by continuous cell tracking (Fig-
ure 3E; Movie S1). As expected, LT-HSC derived pedi-
grees containing any megakaryocytic progeny were almost
absent when GADD45G was expressed (Figure 3F). We
counted the death of cells that express GADD45G, but
are not already committed to the GM lineage, thereby
resembling an uncommitted or ME committed stage.
Substantially more cell-death events appeared when
GADD45G was expressed, in comparison to the control,
suggesting a selective mechanism of cells that are
committed to the ME lineage (Figure 3G). Indeed,
when we transduced prospectively isolated MEPs with
GADD45G, then colony formation was inhibited (Fig-
ure 3H). This inhibition did not appear in transduced
GMPs (Figure 3I). Furthermore, when we cultured MEPs
in cytokine conditions that promote megakaryo-/erythro-
poiesis, GADD45G transduction resulted in the disappear-
ance of all transduced cells, whereas GADD45G-expressing
GMPs in GM supporting cytokine conditions developed
normally (Figure S3). This clearly indicates that the differ-
entiation program that is induced by GADD45G is not
compatible with ME cell fate.
GADD45G Activates MAPK p38, but Not JNK, for
Differentiation Induction
GADD45G collaboratively operates with a variety of other
factors to orchestrate its various functions (Moskalev
et al., 2012). One pathway that has been uncovered is
the ability of GADD45G to activate the mitogen-activated
protein kinase (MAPK) p38 pathway (Mita et al., 2002).
Dimeric GADD45G binds to MAP3K4 near the autoin-
hibitory domain, which results in a conformational
change relieving autoinhibition (Mita et al., 2002). Acti-
vated MAP3K4 phosphorylates MKK3/MKK6, which leads
to p38 and/or JNK phosphorylation. To elucidate the
involvement of this pathway in the differentiation induc-
tion by GADD45G, we cultured LT-HSCs transduced with
GADD45G in the presence of four p38 inhibitors with
distinct pharmacokinetics. The used concentrations highly
restricted the selectivity of these inhibitors to the p38a iso-
form. In the absence of any inhibitor, only 26% of imma-
ture HSPCs expressing GADD45G remained in culture after
5 days, whereas more than 58% of cells resembled imma-
ture HSPCs in the control conditions (Figure 4A). With
any of the four inhibitors, the fast differentiation induction
by GADD45G was inhibited, and the cells behaved similar
to conditions without ectopic GADD45G (Figure 4A).
Along the same line, whereas already 17%mature GM cellsappeared by GADD45G expression after 5 days without
inhibitors, the differentiation was completely abrogated
by p38 inhibition (Figure 4B).
The activation of MAP3K4 also mediates phosphoryla-
tion of JNK. However, the differentiation induction
by GADD45G was not blocked by two JNK inhibitors,
SP600125 and JNK-IN-8 (Figures 4C–4E), suggesting that
GADD45G selectively leads to p38 activation. Next, we
tested the phosphorylation status of p38 and one of its
common downstream targets, MAPK-activated kinase 2
(MK2), after GADD45G expression in MPPs by phos-
phoflow cytometry. Indeed, cells expressing GADD45G
showed a remarkable increase in p38 (Figure 4F) and MK2
phosphorylation (Figure 4G). To further investigate the
molecular link between GADD45G and p38 phosphory-
lation, we tested potential GADD45G downstream mole-
cules, namely, MAP3K4 and MKK6, for their ability to
phenocopy GADD45G-mediated differentiation induc-
tion. We could show that lentivirally expressed constitu-
tively active mutants of MAP3K4 and MKK6 induce and
accelerate the differentiation in LT-HSCs similar to
GADD45G (Figures 4H and 4I), that p38 is activated in all
cases (Figures S4A and S4B), and that the accelerated differ-
entiation is blocked by p38 inhibition (Figures 4H and 4I).
These results strongly suggest that GADD45G activates a
cascade of MAP3K4-MKK6-p38 leading to differentiation
induction in HSPCs.DISCUSSION
We determined GADD45G as a molecular link between
differentiation-promoting cytokine signaling and the
rapid differentiation induction in murine LT-HSCs (Fig-
ure S4C). GADD45G acts like a toggle switch in HSCs.
Although the mRNA and the protein are expressed only
at low levels in steady state, GADD45G expression can
rapidly be triggered by cytokine stimulation via the tran-
scription factors STAT5A/B (Hoffmeyer et al., 2001).
Dimeric GADD45G initiates an activation cascade lead-
ing to phosphorylated p38 and thereby to differentiation
induction. Once GADD45G is upregulated in LT-HSCs,
the differentiation commitment has occurred, and the
cells are unable to maintain self-renewal. In the presence
of IL-3 and IL-6, both potent inducers of GADD45G, sin-
gle LT-HSCs lose their stem cell capacity within 3 days in
culture, whereas the cells rapidly expand (Ema et al.,
2000).
As recently reported, the inactivation of p38 activity by
small molecule inhibitors maintained stemness ex vivo in
human and murine HSCs (Baudet et al., 2012; Zou et al.,
2012). Furthermore, an increase in reactive oxygen species
results in the activation of p38 and finally in HSCStem Cell Reports j Vol. 3 j 34–43 j July 8, 2014 j ª2014 The Authors 39
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Figure 4. GADD45G Induces Differentiation by Specifically Activating MAPK p38
(A–D) Five day culture of transduced LT-HSCs in the presence of p38 (A and B) or JNK inhibitors (C and D). FACS for immature HSPCs
(A and C) and mature GM cells (B and D). n = 3 experiments.
(E) Positive control for JNK inhibitor activity by reduced NIH 3T3 expansion. n = 3 experiments.
(F and G) (F) FACS histogram and quantification of phosphorylated p38 and (G) phosphorylated MK2 in 5 day-cultured MPPs after GADD45G
or control transduction by phosphoflow cytometry. MFI, mean fluorescence intensity (n = 3 experiments).
(legend continued on next page)
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Hematopoietic Differentiation Induction by GADD45Gexhaustion (Ito et al., 2006). We could completely abrogate
the GADD45G induced differentiation by inhibiting acti-
vated p38. Phosphorylated p38 activates GATA-3 and leads
to GATA-3 nuclear translocation specifically in LT-HSCs re-
sulting in an exit of their self-renewal program (Frelin et al.,
2013). Here, we provide the missing upstream molecular
link between p38-mediated GATA3 activation (Frelin
et al., 2013) and cytokine-induced differentiation induc-
tion in LT-HSCs, by our findings of GADD45G-mediated
activation of p38. Hence, these results may open avenues
to uncouple the cytokine-induced cell fates of differentia-
tion from cell-cycle progression, for advanced ex vivo
expansion of HSCs.
By continuously observing hundreds of individual HSCs
and their progeny during differentiation, we can exclude
a change in cell-cycle length in HSPCs upon GADD45G
expression, which was unexpected, because studies on
solid tissue cells reported a G2/M cell-cycle arrest mediated
by GADD45G (Vairapandi et al., 2002). Also, the activation
of p38 has been described as a decision point between
senescence and apoptosis (Tront et al., 2006). None of these
fates were observed in HSCs upon GADD45G expression.
Intriguingly, the differentiation kinetics permitted by
GADD45G is very fast: HSCs are driven to differentiate
into GMPs within 36 hr. During GADD45G-accelerated
differentiation, the metastable progenitor stages seem un-
changed but are temporally shortened to a minimum.
This finding opens a new perspective of our current
understanding of sequential differentiation programs in
hematopoiesis.
Stressed cells with an inability to repair their damage
are committed to undergo apoptosis to prevent transfor-
mation. Alternatively, the induction of terminal differen-
tiation preserves the integrity of the blood system. This
safety mechanism was proposed as a function of the
transcription factor BATF in aged HSCs to eliminate
damaged HSCs from the system (Wang et al., 2012).
The enhanced expression of GADD45G in aged HSCs,
and the finding that aged GADD45G-depleted HSCs
show an increased self-renewal and accumulation
(Wang et al., 2012), may indicate a role of GADD45G
in HSC life span control. Further, the epigenetic inactiva-
tion of Gadd45g in many malignancies explains the
inability of tumor cells to terminally differentiate (Lieber-
mann et al., 2011). Further studies are warranted to uti-
lize the GADD45G-mediated pathway to therapeutically
switch misregulated self-renewal in cancer-initiating cells
into differentiation.(H and I) Five day culture of transduced LT-HSCs in the absence/presen
GM cells (I). n = 4 experiments.
ca, constitutively active; M3K4, MAP3K4. Stars above inhibitor condit
represented as mean ± SD. *p < 0.05, **p < 0.01. ns, not significantEXPERIMENTAL PROCEDURES
Mice
C57BL/6, B6.SJL, andGadd45g/ (Gadd45gtm1Flv [Lu et al., 2001]),
all maintained in C57BL/6 background, were used at 10–14 weeks
of age. Animal experiments were approved by the regional council.
Ex Vivo Differentiation
One hundred LT-HSCs were lentivirally transduced (MOI 100) and
cultured in SFEM (STEMCELL Technologies) supplemented with
100 ng/ml SCF and TPO (PeproTech). Cells were analyzed by
FACS (antibodies against CD48, CD117, CD16/32, CD11b). Inhib-
itors were used as follows: BIRB796 (0.4 mM), SB203580 (10 mM),
VX-702 (1 mM), LY2228820 (0.1 mM, all from Selleck), SP600125
(12.5 mM), and JNK-IN-8 (1 mM, from Merck).
FACS
BM cells were subjected to lineage depletion (EasySep Biotin
Selection Kit, STEMCELL Technologies) and HSPC populations
were sorted with a FACS Aria (BD Biosciences) after staining with
antibodies against CD117, Sca1, CD150, CD48, CD16/32, CD34,
and Streptavidin (Figure S1A; Table S1). Viable sorted cells were
counted with trypan blue exclusion.
Colony Formation Assay
LT-HSCs, GMPs, andMEPs were lentivirally transduced (MOI 100),
seeded 24 hr later in M3434 medium (STEMCELL Technologies),
and scored microscopically after 9–12 days for transduction and
colony formation.
Time-Lapse Imaging and Cell Tracking
Microscopy and tracking of LT-HSCs were performed as described
(Rieger et al., 2009), until the fate of all progeny in the fifth cell
generation was determined.
Statistics
Significance was determined by a t test (two-tailed, unpaired,
unequal).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, one table, and one movie and can be
found with this article online at http://dx.doi.org/10.1016/j.
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